Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations

BACKGROUND: An institutional review board-approved, multicenter clinical trial was designed to determine the efficacy and outcome of percutaneous laser ablation (PLA) in the treatment of invasive ductal breast carcinoma (IDC). Post-ablation magnetic resonance imaging (MRI) was compared with surgical...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartzberg, Barbara, Lewin, John, Abdelatif, Osama, Bernard, Jacqueline, Bu-Ali, Hanadi, Cawthorn, Simon, Chen-Seetoo, Margaret, Feldman, Sheldon, Govindarajulu, Sasirekha, Jones, Lyn, Juette, Arne, Kavia, Sanjay, Maganini, Robert, Pain, Simon, Shere, Mike, Shriver, Craig, Smith, Simon, Valencia, Alexandra, Whitacre, Eric, Whitney, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208881/
https://www.ncbi.nlm.nih.gov/pubmed/29987603
http://dx.doi.org/10.1245/s10434-018-6623-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208881/
https://www.ncbi.nlm.nih.gov/pubmed/29987603
http://dx.doi.org/10.1245/s10434-018-6623-2

Ejemplares similares